Cure My Disease

Don't miss your cure!

 Log in / Sign up

Silkam stitches studied in 161 patients – infection rates tracked

NCT ID NCT05225714

Knowledge-focused Sponsor: Aesculap AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well Silkam suture material performs when used to close skin wounds from cuts, bruises, or surgery. Researchers tracked 161 patients to see how many developed a surgical site infection. The goal was to gather real-world information about the safety and performance of this stitching material.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Silkam suture material

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

161 people

The number who actually took part.

Started

Jul 2022

Finished

Jun 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult and paediatric patients undergoing skin closure

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult and paediatric patients undergoing skin closure using Silkam® as suture material. * Written informed consent regarding the data collection for the PMCF study. Exclusion Criteria: * Pregnancy * Visible dirty wounds * Patients taking medication that might affect wound healing * Patients with hypersensitivity or allergy to the suture material

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contusions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Contusions Lacerations Surgical Wound

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contusions Incision Laceration

Contacts and locations

Locations

  • Hospital Universitari Germans Trias i Pujol

    Badalona, 08916, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.